Re-launched in November 2016 and published on the 2nd and 4th Thursdays of each month, the Cannabis Stock Report is designed to be the most unique, cost-effective, value-added Cannabis research product available. We are primed to broadly achieve this objective via an innovative approach that combines:
The Cannabis Stock Report differs from other products on the market and even our own offerings, due to an approach that seeks to provide elements of institutional research reports and retail trading newsletters with a focus on outsized gains through specific guidance and expectations that reduce risk and enhance reward. The early institutional research offerings in the space read like term papers and highlight only the big names along with others that carry little relevance beyond the big picture. Moreover, these reports are reactive in nature rather than proactive. Trading reports are great tools for short term trading but carry higher risk and can lack comprehensive coverage.
Instead, the Cannabis Stock Report offers individual reports on key names in varied vertical markets of the entire Cannabis food chain. Importantly, each profiled company report carries a 3 month, 6 month, and 12 month price target, and we will routinely provide trading guidance on the buy and sell side, by incorporating a top-down, bottom-up approach. Moreover, our stock selections will not be bound by market cap or trading volume. In fact, we will even profile private companies we believe will soon go public and include prospective valuations. Of course, our publications will also highlight relevant industry and stock category information and insights.
Each issue of Cannabis Stock Report includes a company report, updates, company catalysts, policy and stock category information and trading guidance, along with other data and insights.
For a limited time, we are offering a six month introductory subscription (12 issues) of this publication for only $99 versus the $249 annual subscription price! By subscribing now you get the first 2016 issue of Cannabis Stock Report, and a new edition twice a month for the next six months directly in your inbox---all for just $99!
There are many public companies in the space currently trading and a slew of organizations providing varying levels of research and trading information. These valuable providers serve critical components of the nascent market but the current evolution and high risk nature signal that a new research offering is needed for the investing public.
It's Deja Vu All Over Again
From the earliest of stages, the mantra of industry pundits has been to dub this opportunity as the second coming of the end of the Prohibition Era. While it may be true to an extent, that comparison does not do it justice for the potential is far greater based on recent legislative wins, which is why investment banks are now treating its coverage much like other industry segments. Unfortunately, they are not incorporating the right companies, providing trading and investment insights and perspectives, are focused on large firms, and omitting exciting private companies.
I was fortunate to lead an institutional research team that was the go-to source for research coverage on a country that went through significant shifts which resulted in an economy changing almost overnight. What happened? In just a few years, over 100 companies went public in the technology and health care arena, became niche leaders, and were acquired by major players seeking to gain critical mass through acquisition rather than building products and a food chain from scratch.
We see the same things happening with the cannabis space. The early players and bottom feeders and Mom and Pops are soon destined to disappear leaving bigger, better financed players with real business experience. Interestingly, the “untold story” is the migration of seasoned business leaders moving from the corporate world to the start-up world in the marijuana industry. We saw this first hand as investment bankers and hands-on consultants in the dot-com and post-dot-com booms. These veterans are taking their experiences, corporate processes and procedures and contacts to make a mark in a space dominated by also-rans, opportunists and weak operators. It will be like shooting fish in a barrel.
That’s why our newsletter emphasizes the symbiotic relationship between the political, economic, market, capital markets, and leadership phases to identify the real future players, both public and private as favorable investments and trades abound.
Subscribe now and get six months worth of issues for just $99. You don't want to miss this limited opportunity. Plus, the next issue is just days away!